Cognition Therapeutics, Inc.CGTXNASDAQ
Loading
Net Income Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year net income growth rate

Latest
26.79%
↑ 168% vs avg
Percentile
P86
Within normal range
Streak
2 qtr
Consecutive growthAccelerating
Average
-39.30%
Historical baseline
PeriodValue
Q3 202526.79%
Q2 202520.59%
Q1 2025-8.14%
Q4 202421.08%
Q3 2024-41.13%
Q2 202423.06%
Q1 2024-12.41%
Q4 2023-20.63%
Q3 2023-42.81%
Q2 202323.43%
Q1 2023-19.10%
Q4 202221.78%
Q3 2022-15.18%
Q2 2022-49.87%
Q1 202247.70%
Q4 2021-135.98%
Q3 2021-108.72%
Q2 2021-768.16%
Q1 2021111.94%
Q4 2020-4.30%
Q3 2020-6.99%
Q2 202033.20%
Q1 20200.00%